[HTML][HTML] Hepatocyte growth factor: new arsenal in the fights against renal fibrosis?
Y Liu, J Yang - Kidney international, 2006 - Elsevier
Y Liu, J Yang
Kidney international, 2006•ElsevierHepatocyte growth factor (HGF) has emerged as a potent, endogenous antifibrotic factor that
shows an impressive efficacy in ameliorating tissue fibrosis in a wide variety of animal
models. Herrero-Fresneda et al. provide new evidence demonstrating that intramuscular
injection of HGF gene reduces mortality, inflammation, and renal fibrosis in chronic allograft
nephropathy.
shows an impressive efficacy in ameliorating tissue fibrosis in a wide variety of animal
models. Herrero-Fresneda et al. provide new evidence demonstrating that intramuscular
injection of HGF gene reduces mortality, inflammation, and renal fibrosis in chronic allograft
nephropathy.
Hepatocyte growth factor (HGF) has emerged as a potent, endogenous antifibrotic factor that shows an impressive efficacy in ameliorating tissue fibrosis in a wide variety of animal models. Herrero-Fresneda et al. provide new evidence demonstrating that intramuscular injection of HGF gene reduces mortality, inflammation, and renal fibrosis in chronic allograft nephropathy.
Elsevier